Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.80103.90-50.38-3.8346.34

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 19.80 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.80
Mar2024103.90
Mar2023-50.38
Mar2022-3.83
Mar202146.34

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.8
-80.94
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,399.0 Cr 1.8% -8.4% 48.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,994.0 Cr -0% -4.5% 15.9% Stock Analytics
DIVIS LABORATORIES ₹240,249.0 Cr 5.9% 16.1% 49.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,135.0 Cr 3% 3% 34% Stock Analytics
CIPLA ₹114,708.0 Cr -0.4% -3.6% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.9 Cr NA 2.8% -7.1% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

1.8%

-8.4%

48.5%

SENSEX

-0.8%

0.2%

-6%


You may also like the below Video Courses